U.S. flag

An official website of the United States government

Filters

See more specimen types...
See more states

Other countries

See more countries

Results: 1 to 20 of 68

Tests names and labsConditionsGenes, analytes, and microbesMethods

Neuromuscular Gene Panel

Mayo Clinic Laboratories Mayo Clinic
United States
1216
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Spinal Muscular Atrophy (SMA) Dosage Analysis

Institute for Genomic Medicine (IGM) Clinical Laboratory Nationwide Children's Hospital
United States
12
  • X Mutation scanning of select exons

Motor Neuropathy Gene Panel

Mayo Clinic Laboratories Mayo Clinic
United States
826
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

NewbornGeneID

GeneID Lab - Advanced Molecular Diagnostics
United States
7361
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

SMN1 & SMN2 - MLPA

Centogene AG - the Rare Disease Company
Germany
42
  • D Deletion/duplication analysis

Neuromuscular Panel

Centogene AG - the Rare Disease Company
Germany
325316
  • D Deletion/duplication analysis
  • X Mutation scanning of select exons
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

SMA Diagnostic Test

Quest Diagnostics Nichols Institute San Juan Capistrano
United States
12
  • D Deletion/duplication analysis

Spinal muscular atrophy, type III, modifier of, 253400, Autosomal recessive (Proximal spinal muscular atrophy type 3) (Prenatal) (MLPA)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • D Deletion/duplication analysis

Spinal muscular atrophy, type III, modifier of, 253400, Autosomal recessive (Proximal spinal muscular atrophy type 3) (SMN2 gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

Spinal muscular atrophy, type III, modifier of, 253400, Autosomal recessive (Proximal spinal muscular atrophy type 3) (SMN2 gene) (Sequence Analysis-All Coding Exons) (Prenatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

Spinal muscular atrophy, type III, modifier of, 253400, Autosomal recessive (Proximal spinal muscular atrophy type 3) (MLPA)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • D Deletion/duplication analysis

Genomic Unity Motor Neuron Disorders Analysis (includes AR, C9ORF72 STR analysis)

Variantyx, Inc.
United States
14118
  • D Deletion/duplication analysis
  • X Mutation scanning of select exons
  • C Sequence analysis of the entire coding region

Spinal Muscular Atrophy via MLPA of SMN1 and SMN2

PreventionGenetics, part of Exact Sciences
United States
42
  • D Deletion/duplication analysis

Invitae Spinal Muscular Atrophy Panel

Invitae
United States
42
  • D Deletion/duplication analysis

Invitae Hereditary Motor Neuropathy Panel

Invitae
United States
6026
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Invitae Comprehensive Neuropathies Panel

Invitae
United States
20196
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Invitae Comprehensive Neuromuscular Disorders Panel

Invitae
United States
353208
  • D Deletion/duplication analysis

Spinal Muscular Atrophy (SMA), Fetus

Quest Diagnostics Nichols Institute San Juan Capistrano
United States
12
  • D Deletion/duplication analysis

SMA Carrier Screen

Quest Diagnostics Nichols Institute San Juan Capistrano
United States
12
  • T Targeted variant analysis

Spinal Muscular Atrophy (SMN1 and SMN2)

UCSF Molecular Diagnostics Laboratory University of California, San Francisco
United States
12
  • T Targeted variant analysis

Results: 1 to 20 of 68

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.